HBOT Billing: CPT 99183, G0277, and LCD Compliance

HBOT Billing Basics: Two Codes, Two Sides of the Claim

Hyperbaric oxygen therapy (HBOT) billing runs on two separate codes, and confusing them is one of the most common reasons practices see denials. CPT 99183 covers the physician or qualified healthcare professional (QHP) who attends the patient during the pressurized session. G0277 covers the facility fee for the hyperbaric chamber sessions billed in a hospital outpatient or ambulatory setting. In an office-based HBOT practice, you are billing 99183 only — the facility component rolls into your overhead.

Understanding the split is foundational for HBOT billing in wound care. If your practice owns the chamber, you capture 99183 as a professional service. If you refer to a hospital outpatient hyperbaric program and attend, you still bill 99183 — the facility bills G0277 separately. If you refer and do not attend, neither code is yours to bill.

CPT 99183 — What "Attendance" Actually Means

Medicare defines attendance under 99183 as physical presence in the facility during the hyperbaric session, ready to respond. The physician or QHP does not have to be in the chamber — but they cannot be conducting separate patient encounters or be off-site. CMS expects the attending provider to evaluate the patient before and after each session, document observations, and be immediately available throughout the pressurized period.

The Medically Unlikely Edit (MUE) for 99183 is 1 unit per date of service per rendering provider. You cannot bill two units of 99183 for a single patient session, and you cannot bill 99183 for two separate patients you attend simultaneously if those sessions overlap in time.

G0277 — Facility-Side Billing

G0277 is billed by the facility (hospital outpatient, ambulatory care center) for each hyperbaric session, up to the number of covered sessions. It is not on the physician fee schedule. If you are a mobile wound care practitioner or office-based provider, G0277 is not your code.

Medicare LCD Coverage for HBOT

Medicare HBOT coverage is governed at both the national and local level. NCD 20.29 establishes the foundational national coverage policy: HBOT is covered only for specific indications. For wound care, the primary covered indications are:

Chronic refractory osteomyelitis (failed standard management)
Osteoradionecrosis as an adjunct to conventional treatment
Soft tissue radionecrosis
Diabetic wounds of the lower extremity (Wagner grade III or higher, or equivalent depth) that have not responded to standard wound care for at least 30 days
Acute traumatic peripheral ischemia and crush injuries

The diabetic wound indication is the one wound care practices encounter most. The 30-day standard-care failure requirement is not discretionary — it is a hard LCD coverage threshold. Document the wound care provided during those 30 days in detail: modality used, dressing type, frequency of visits, wound measurements at each visit, and clinical response (or lack of it).

Local Coverage Determinations from your MAC add additional documentation specificity. Noridian, Novitas, CGS, and other MACs generally require a signed physician order, a pre-treatment vascular assessment (ABI or TcPO2 confirming adequate perfusion for benefit), a documented treatment plan with expected number of sessions, and progress notes for each session that include wound status and response to treatment. Refer to your MAC's LCD directly for exact requirements — the pillar on wound care LCD compliance walks through how to locate and interpret the relevant policies.

Session Limits and Documentation for Extended Courses

A standard HBOT course for diabetic lower extremity wounds is approximately 20–40 sessions. Medicare does not impose a hard session cap nationally, but MACs scrutinize anything beyond 30–40 sessions heavily. To support an extended course:

Document wound measurement at each session or at minimum weekly
Provide objective evidence of improvement (reduction in wound dimensions, eschar resolution, granulation progression)
Include a physician attestation that continued treatment is medically necessary and that the wound is responding

If there is no measurable improvement after 20–30 sessions, continued treatment is difficult to defend. Document your clinical rationale explicitly or discontinue the course.

Billing 99183 on the Same Day as Wound Care Procedures

This is a frequent billing edge case in wound care HBOT programs. Many patients receiving HBOT also receive wound debridement, dressing changes, or evaluation and management services on the same date. Here is how to handle each combination:

99183 + Debridement (CPT 11042, 11043, 97597, 97598): These can be billed together on the same date of service when performed separately and documented independently. The debridement requires its own procedure note with wound measurements, tissue type removed, and clinical rationale. No modifier is required between 99183 and a surgical debridement code — they are not bundled in the NCCI edits.

99183 + Evaluation and Management (99202–99215): When you perform a substantive, separately identifiable E&M service on the same date as HBOT attendance, append Modifier 25 to the E&M code. The E&M documentation must stand on its own — a pre-HBOT check-in that does not meet MDM or time thresholds is not a separately billable E&M. See the wound care CPT codes 2026 guide for documentation thresholds by E&M level.

99183 + Skin Substitute Application: Skin substitute application (CPT 15271–15278) and HBOT attendance on the same date is unusual but not prohibited. Each service needs independent documentation. If the same provider performs both, ensure the notes are clearly separate and each stands alone.

Non-Covered Indications and the ABN Requirement

Not every wound qualifies for Medicare HBOT coverage. Venous leg ulcers, pressure injuries, arterial ulcers without concurrent diabetic pathology, and wounds below Wagner grade III typically fall outside covered indications. When you provide HBOT for a non-covered indication — or when a patient's wound does not meet the LCD documentation threshold — an Advance Beneficiary Notice of Non-Coverage (ABN) is required before the service is delivered.

The ABN must be specific: identify the service, explain why Medicare may not cover it, and state the estimated cost. A generic or undated ABN does not protect you from liability. If the patient signs the ABN, bill with Modifier GA appended to 99183 to indicate the ABN is on file. If no ABN was obtained for a non-covered service, do not bill — you cannot hold the patient financially responsible.

Documentation Checklist for Each HBOT Session

The following elements can support a defensible HBOT claim:

Patient identifier, date, session number in course
Attending provider name, credentials, and signature
Time of session start and end (some LCDs require this)
Patient's pre-session status: vital signs, wound appearance
Session parameters: pressure (ATA), duration, oxygen delivery method
Patient tolerance: any adverse events or interruptions
Post-session assessment: wound status, any complications
Progress toward treatment goals

Keep this documentation in the chart and readily accessible. HBOT programs are a recurring audit target for MACs. If your program gets an Additional Documentation Request (ADR), every session note will be reviewed.

Key Takeaways

CPT 99183 covers physician/QHP attendance at each HBOT session; G0277 is the facility fee — office-based practices bill 99183 only
Medicare covers HBOT for specific wound indications under NCD 20.29; diabetic wounds require documented 30-day failure of standard care before HBOT begins
Your MAC's LCD sets the specific documentation requirements — locate it, print it, and build your intake and progress note templates around it
Modifier 25 is required when billing an E&M on the same day as 99183; debridement codes can be billed same-day without a modifier
Non-covered indications require a signed ABN before service; bill Modifier GA when an ABN is on file
HBOT courses beyond 30–40 sessions require objective evidence of wound improvement and a physician attestation of continued medical necessity